{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:47:00Z","timestamp":1793227620209,"version":"4.5.0"},"reference-count":157,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202406780015"],"award-info":[{"award-number":["202406780015"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Nutrition"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.advnut.2026.100647","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T07:07:36Z","timestamp":1778137656000},"page":"100647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dietary Fiber and Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Converging Mechanisms, Interactions, and Strategies for Durable Weight Control"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9328-4001","authenticated-orcid":false,"given":"Yuxin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Verbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naschla Gasaly","family":"Retamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Akkerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"de Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.advnut.2026.100647_bib1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","article-title":"Global, regional, and national prevalence of adult overweight and obesity, 1990\u20132021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021","volume":"405","author":"Ng","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.advnut.2026.100647_bib2","first-page":"26","article-title":"The impact of ultra-processed foods on obesity risk: a comprehensive bibliometric analysis","volume":"61","author":"Agjei","year":"2025","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.advnut.2026.100647_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101850","article-title":"Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019","volume":"57","author":"Chong","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.advnut.2026.100647_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/diseases13020055","article-title":"The human energy balance: uncovering the hidden variables of obesity","volume":"13","author":"Theodorakis","year":"2025","journal-title":"Diseases"},{"issue":"Suppl 1","key":"10.1016\/j.advnut.2026.100647_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/dom.14270","article-title":"An overview of obesity mechanisms in humans: endocrine regulation of food intake, eating behaviour and common determinants of body weight","volume":"23","author":"Theilade","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.advnut.2026.100647_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.70027","article-title":"The gut\u2013brain axis in appetite, satiety, food intake, and eating behavior: insights from animal models and human studies","volume":"12","author":"Clarke","year":"2024","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.advnut.2026.100647_bib7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41574-019-0168-8","article-title":"Function and mechanisms of enteroendocrine cells and gut hormones in metabolism","volume":"15","author":"Gribble","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"8","key":"10.1016\/j.advnut.2026.100647_bib8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41573-025-01183-8","article-title":"GLP-1-based therapies for diabetes, obesity and beyond","volume":"24","author":"Drucker","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.advnut.2026.100647_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12986-016-0153-3","article-title":"Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review","volume":"13","author":"Bodnaruc","year":"2016","journal-title":"Nutr. Metab. (Lond.)."},{"key":"10.1016\/j.advnut.2026.100647_bib10","article-title":"Glucagon-like peptide agonists: a prospective review, Endocrinol","volume":"7","author":"Mariam","year":"2024","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.advnut.2026.100647_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/jcm12010145","article-title":"Clinical recommendations to manage gastrointestinal adverse events in patients treated with Glp-1 receptor agonists: a multidisciplinary expert consensus","volume":"12","author":"Gorgojo-Mart\u00ednez","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.advnut.2026.100647_bib12","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.advnut.2026.100647_bib13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2147\/PPA.S187907","article-title":"Patient preferences for glucagon-like peptide 1 receptor\u2013agonist treatment attributes","volume":"13","author":"Thieu","year":"2019","journal-title":"Patient Prefer. Adherence."},{"key":"10.1016\/j.advnut.2026.100647_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12933-020-01211-4","article-title":"Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review","volume":"20","author":"Yang","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.advnut.2026.100647_bib15","first-page":"1986","article-title":"Memory improvement in senile rats after prebiotic and probiotic supplementation is not induced by GLP-1, CNS Neurosci","volume":"28","author":"Serv\u00edn-Casas","year":"2022","journal-title":"Ther"},{"key":"10.1016\/j.advnut.2026.100647_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196579","article-title":"Barley \u03b2-glucan improves metabolic condition via short-chain fatty acids produced by gut microbial fermentation in high fat diet fed mice","volume":"13","author":"Miyamoto","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1016\/j.advnut.2026.100647_bib17","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.3390\/molecules27207111","article-title":"Research progress on hypoglycemic mechanisms of resistant starch: a review","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.advnut.2026.100647_bib18","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s12276-020-0449-2","article-title":"The effects of different dietary fiber pectin structures on the gastrointestinal immune barrier: impact via gut microbiota and direct effects on immune cells","volume":"52","author":"Beukema","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.advnut.2026.100647_bib19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/ajcn\/nqz292","article-title":"Can dietary viscous fiber affect body weight independently of an energy-restrictive diet? A systematic review and meta-analysis of randomized controlled trials","volume":"111","author":"Jovanovski","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.advnut.2026.100647_bib20","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.advnut.2026.100647_bib21","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/ajcn\/nqac184","article-title":"The effect of fiber supplementation on chronic constipation in adults: an updated systematic review and meta-analysis of randomized controlled trials","volume":"116","author":"van der Schoot","year":"2022","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.advnut.2026.100647_bib22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/sj.ejcn.1600687","article-title":"Relationships between transit time in man and in vitro fermentation of dietary fiber by fecal bacteria","volume":"54","author":"El Oufir","year":"2000","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.advnut.2026.100647_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26502\/aimr.0189","article-title":"Semaglutide: double-edged sword with risks and benefits","volume":"8","author":"Pillarisetti","year":"2025","journal-title":"Arch. Intern. Med. Res."},{"key":"10.1016\/j.advnut.2026.100647_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"M\u00fcller","year":"2019","journal-title":"Mol. Metab."},{"key":"10.1016\/j.advnut.2026.100647_bib25","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4239\/wjd.v7.i20.572","article-title":"Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity","volume":"7","author":"Anandhakrishnan","year":"2016","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.advnut.2026.100647_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.peptides.2015.07.019","article-title":"Signalling pathways involved in the detection of peptones by murine small intestinal enteroendocrine L-cells","volume":"77","author":"Pais","year":"2016","journal-title":"Peptides"},{"key":"10.1016\/j.advnut.2026.100647_bib27","doi-asserted-by":"crossref","first-page":"E1160","DOI":"10.1152\/ajpendo.90637.2008","article-title":"Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents","volume":"295","author":"Zhou","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.advnut.2026.100647_bib28","doi-asserted-by":"crossref","first-page":"32913","DOI":"10.1074\/jbc.M805601200","article-title":"Conserved polar residues in transmembrane domains V, VI, and VII of free fatty acid receptor 2 and free fatty acid receptor 3 are required for the binding and function of short chain fatty acids","volume":"283","author":"Stoddart","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.advnut.2026.100647_bib29","doi-asserted-by":"crossref","first-page":"25481","DOI":"10.1074\/jbc.M301403200","article-title":"Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation","volume":"278","author":"Poul","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.advnut.2026.100647_bib30","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2337\/db11-1019","article-title":"Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein\u2013coupled receptor FFAR2","volume":"61","author":"Tolhurst","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.advnut.2026.100647_bib31","doi-asserted-by":"crossref","first-page":"G53","DOI":"10.1152\/ajpgi.00346.2017","article-title":"The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon","volume":"315","author":"Christiansen","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.advnut.2026.100647_bib32","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0016-5085(82)80339-9","article-title":"Utilization of nutrients by isolated epithelial cells of the rat colon","volume":"83","author":"Roediger","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.advnut.2026.100647_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1113\/jphysiol.2004.076414","article-title":"Characterization and functional role of voltage gated cation conductances in the glucagon-like peptide-1 secreting GLUTag cell line","volume":"563","author":"Reimann","year":"2005","journal-title":"J. Physiol."},{"key":"10.1016\/j.advnut.2026.100647_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2024.171200","article-title":"Immunomodulation and inflammation: role of GLP-1R and GIPR expressing cells within the gut","volume":"176","author":"Morrow","year":"2024","journal-title":"Peptides"},{"key":"10.1016\/j.advnut.2026.100647_bib35","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1126\/science.adj2537","article-title":"GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans","volume":"385","author":"Kim","year":"2024","journal-title":"Science"},{"issue":"Suppl 2","key":"10.1016\/j.advnut.2026.100647_bib36","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/S1262-3636(08)73398-6","article-title":"GLP-1 receptor signaling: effects on pancreatic \u03b2-cell proliferation and survival","volume":"34","author":"Buteau","year":"2008","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.advnut.2026.100647_bib37","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13852","article-title":"GLP-1 suppresses glucagon secretion in human pancreatic alpha-cells by inhibition of P\/Q-type Ca2+ channels","volume":"6","author":"Ramracheya","year":"2018","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.advnut.2026.100647_bib38","doi-asserted-by":"crossref","first-page":"R885","DOI":"10.1152\/ajpregu.00520.2015","article-title":"GLP-1 and weight loss: unraveling the diverse neural circuitry","volume":"310","author":"Kanoski","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.advnut.2026.100647_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2967\/jnmt.123.266800","article-title":"Glucagonlike peptide-1 receptor agonists: the good, the bad, and the ugly-benefits for glucose control and weight loss with side effects of delaying gastric emptying","volume":"52","author":"Parkman","year":"2024","journal-title":"J. Nucl. Med. Technol."},{"key":"10.1016\/j.advnut.2026.100647_bib40","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.advnut.2026.100647_bib41","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1111\/all.15430","article-title":"Role of dietary fiber in promoting immune health\u2014an EAACI position paper","volume":"77","author":"Venter","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.advnut.2026.100647_bib42","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41423-020-00625-0","article-title":"Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids","volume":"18","author":"Kim","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.advnut.2026.100647_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.chom.2017.11.003","article-title":"Fiber-mediated nourishment of gut microbiota protects against diet-induced obesity by restoring IL-22-mediated colonic health","volume":"23","author":"Zou","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.advnut.2026.100647_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1865706","article-title":"Bacteroides uniformis combined with fiber amplifies metabolic and immune benefits in obese mice","volume":"13","author":"L\u00f3pez-Almela","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.advnut.2026.100647_bib45","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jgr.2025.01.006","article-title":"Effects of red ginseng extract and red ginseng dietary fiber on the maintenance of intestinal immune and functional homeostasis in diet-induced obese mice","volume":"49","author":"Seo","year":"2025","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.advnut.2026.100647_bib46","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0002-8223(02)90346-9","article-title":"Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids","volume":"102","author":"Trumbo","year":"2002","journal-title":"J. Am. Diet. Assoc."},{"key":"10.1016\/j.advnut.2026.100647_bib47","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.nut.2004.08.018","article-title":"Dietary fiber and body weight","volume":"21","author":"Slavin","year":"2005","journal-title":"Nutrition"},{"key":"10.1016\/j.advnut.2026.100647_bib48","article-title":"Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases","volume":"15","author":"Zeng","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.advnut.2026.100647_bib49","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.3390\/nu5062093","article-title":"The role of viscosity and fermentability of dietary fibers on satiety- and adiposity-related hormones in rats","volume":"5","author":"Schroeder","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.advnut.2026.100647_bib50","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1039\/D2FO02622H","article-title":"Consumption of barley flour increases gut fermentation and improves glucose intolerance via the short-chain fatty acid receptor GPR43 in obese male mice","volume":"13","author":"Mio","year":"2022","journal-title":"Food Funct"},{"key":"10.1016\/j.advnut.2026.100647_bib51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1017\/S0007114507691648","article-title":"Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats","volume":"98","author":"Cani","year":"2007","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.advnut.2026.100647_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00394-020-02224-1","article-title":"Effect of viscous fiber supplementation on obesity indicators in individuals consuming calorie-restricted diets: a systematic review and meta-analysis of randomized controlled trials","volume":"60","author":"Jovanovski","year":"2021","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.advnut.2026.100647_bib53","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.clnu.2020.10.032","article-title":"Effects of soluble fiber supplementation on glycemic control in adults with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials","volume":"40","author":"Xie","year":"2021","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.advnut.2026.100647_bib54","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/dom.14863","article-title":"Semaglutide for the treatment of overweight and obesity: a review","volume":"25","author":"Bergmann","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.advnut.2026.100647_bib55","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/dc24-1678","article-title":"Efficacy of GLP-1 receptor agonists on weight loss, BMI, and waist circumference for patients with obesity or overweight: a systematic review, meta-analysis, and meta-regression of 47 randomized controlled trials","volume":"48","author":"Wong","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.advnut.2026.100647_bib56","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s42255-024-00988-y","article-title":"Resistant starch intake facilitates weight loss in humans by reshaping the gut microbiota","volume":"6","author":"Li","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.advnut.2026.100647_bib57","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13073-021-00921-y","article-title":"Dietary fiber intake, the gut microbiome, and chronic systemic inflammation in a cohort of adult men","volume":"13","author":"Ma","year":"2021","journal-title":"Genome Med"},{"key":"10.1016\/j.advnut.2026.100647_bib58","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41430-020-00759-4","article-title":"Effects of whey protein and dietary fiber intake on insulin sensitivity, body composition, energy expenditure, blood pressure, and appetite in subjects with abdominal obesity","volume":"75","author":"Fuglsang-Nielsen","year":"2021","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.advnut.2026.100647_bib59","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.3390\/foods11182856","article-title":"The impact of dietary fiber as a prebiotic on inflammation in children with obesity","volume":"11","author":"Visuthranukul","year":"2022","journal-title":"Foods"},{"key":"10.1016\/j.advnut.2026.100647_bib60","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.3390\/nu15214569","article-title":"A new dietary fiber can enhance satiety and reduce postprandial blood glucose in healthy adults: a randomized cross-over trial","volume":"15","author":"Wu","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.advnut.2026.100647_bib61","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/s41591-022-02026-4","article-title":"Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial","volume":"28","author":"Garvey","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.advnut.2026.100647_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.742873","article-title":"Weight loss outcomes among early high responders to exenatide treatment: a randomized, placebo controlled study in overweight and obese women","volume":"12","author":"Rodgers","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.advnut.2026.100647_bib63","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/oby.23772","article-title":"Glucagon-like peptide-1 therapy in people with obesity restores natural killer cell metabolism and effector function","volume":"31","author":"De Barra","year":"2023","journal-title":"Obesity"},{"key":"10.1016\/j.advnut.2026.100647_bib64","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1210\/jc.2018-02685","article-title":"Reductions in insulin resistance are mediated primarily via weight loss in subjects with type 2 diabetes on semaglutide","volume":"104","author":"Fonseca","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.advnut.2026.100647_bib65","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.3390\/foods12112122","article-title":"Effects of four different dietary fibre supplements on weight loss and lipid and glucose serum profiles during energy restriction in patients with traits of metabolic syndrome: a comparative, randomized, placebo-controlled study","volume":"12","author":"Jenko Pra\u017enikar","year":"2023","journal-title":"Foods"},{"key":"10.1016\/j.advnut.2026.100647_bib66","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/jch.14661","article-title":"Effect of weight loss on blood pressure changes in overweight patients: a systematic review and meta-analysis","volume":"25","author":"Yang","year":"2023","journal-title":"J. Clin. Hypertens. (Greenwich)."},{"key":"10.1016\/j.advnut.2026.100647_bib67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.numecd.2017.09.007","article-title":"The effect of viscous soluble fiber on blood pressure: a systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Khan","year":"2018","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.advnut.2026.100647_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107780","article-title":"Reinforcing gut integrity: a systematic review and meta-analysis of clinical trials assessing probiotics, synbiotics, and prebiotics on intestinal permeability markers","volume":"216","author":"Ghorbani","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.advnut.2026.100647_bib69","first-page":"500","article-title":"The effects of prebiotic dietary fibers, probiotics, and synbiotics on gut permeability and immunity: a systematic review, Iran","volume":"50","author":"Maghsoumi-Norouzabad","year":"2025","journal-title":"J. Med. Sci."},{"key":"10.1016\/j.advnut.2026.100647_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.997578","article-title":"GLP-1 receptor agonist as a modulator of innate immunity","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.advnut.2026.100647_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.721135","article-title":"GLP-1 receptor agonists: beyond their pancreatic effects","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.advnut.2026.100647_bib72","article-title":"Mechanisms of action and therapeutic applications of GLP-1 and dual GIP\/GLP-1 receptor agonists","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.advnut.2026.100647_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106320","article-title":"The anti-inflammatory and immunological properties of GLP-1 receptor agonists","volume":"182","author":"Bendotti","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.advnut.2026.100647_bib74","article-title":"The immunomodulatory effects of GLP-1 receptor agonists in neurogenerative diseases and ischemic stroke treatment","volume":"16","author":"Sun","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.advnut.2026.100647_bib75","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1007\/s00125-012-2592-3","article-title":"Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes","volume":"55","author":"Lee","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.advnut.2026.100647_bib76","article-title":"Microglial M2 polarization mediated the neuroprotective effect of morroniside in transient MCAO-induced mice","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.advnut.2026.100647_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173581","article-title":"Glucagon-like peptide-1 cleavage product GLP-1(9\u201336) reduces neuroinflammation from stroke via the activation of insulin-like growth factor 1 receptor in astrocytes","volume":"887","author":"Huang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.advnut.2026.100647_bib78","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmet.2023.11.009","article-title":"Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation","volume":"36","author":"Wong","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.advnut.2026.100647_bib79","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9923537","article-title":"Microglial activation of GLP-1R signaling in neuropathic pain promotes gene expression adaption involved in inflammatory responses","volume":"2021","author":"Ma","year":"2021","journal-title":"Neural Plast"},{"key":"10.1016\/j.advnut.2026.100647_bib80","first-page":"1157","article-title":"Spinal microglial \u03b2-endorphin signaling mediates IL-10 and exenatide-induced inhibition of synaptic plasticity in neuropathic pain, CNS Neurosci","volume":"27","author":"Ma","year":"2021","journal-title":"Ther."},{"key":"10.1016\/j.advnut.2026.100647_bib81","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s12020-019-02081-x","article-title":"Effects of glucagon-like peptide-1 analog liraglutide on the systemic inflammation in high-fat-diet-induced mice","volume":"66","author":"Sha","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.advnut.2026.100647_bib82","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s10020-022-00574-6","article-title":"Exenatide regulates Th17\/Treg balance via PI3K\/Akt\/FoxO1 pathway in db\/db mice","volume":"28","author":"Xu","year":"2022","journal-title":"Mol. Med."},{"key":"10.1016\/j.advnut.2026.100647_bib83","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.3390\/cells11162587","article-title":"Induced human regulatory T cells express the glucagon-like peptide-1 receptor","volume":"11","author":"Rode","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.advnut.2026.100647_bib84","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.cmet.2024.05.001","article-title":"Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule","volume":"36","author":"Ben Nasr","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.advnut.2026.100647_bib85","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.advnut.2026.100647_bib86","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s43587-025-01029-3","article-title":"Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders","volume":"6","author":"Sabbagh","year":"2026","journal-title":"Nat. Aging."},{"key":"10.1016\/j.advnut.2026.100647_bib87","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jnutbio.2018.07.009","article-title":"Liraglutide modulates gut microbiota and reduces NAFLD in obese mice","volume":"62","author":"Moreira","year":"2018","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.advnut.2026.100647_bib88","article-title":"Effects of semaglutide on metabolism and gut microbiota in high-fat diet-induced obese mice","volume":"16","author":"Sun","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.advnut.2026.100647_bib89","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.2147\/DDDT.S381546","article-title":"An effective glucagon-like peptide-1 receptor agonists, semaglutide, improves sarcopenic obesity in obese mice by modulating skeletal muscle metabolism","volume":"16","author":"Ren","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.advnut.2026.100647_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.132256","article-title":"Achyranthes bidentata polysaccharide ameliorates type 2 diabetes mellitus by gut microbiota-derived short-chain fatty acids-induced activation of the GLP-1\/GLP-1R\/cAMP\/PKA\/CREB\/INS pathway","volume":"270","author":"Xia","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.advnut.2026.100647_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1073350","article-title":"Tremella fuciformis polysaccharide reduces obesity in high-fat diet-fed mice by modulation of gut microbiota","volume":"13","author":"He","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.advnut.2026.100647_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.640602","article-title":"Dietary fiber is essential to maintain intestinal size, L-cell secretion, and intestinal integrity in mice","volume":"12","author":"Hunt","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.advnut.2026.100647_bib93","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1038\/s41467-025-59773-4","article-title":"GLP-1R\/GCGR dual agonism dissipates hepatic steatosis to restore insulin sensitivity and rescue pancreatic \u03b2-cell function in obese male mice","volume":"16","author":"Laker","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.advnut.2026.100647_bib94","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/JS9.0000000000001896","article-title":"Semaglutide outperforms insulin in restoring neutrophil function against implant-related infection in diabetic and obese mice: experimental research","volume":"111","author":"Liu","year":"2025","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.advnut.2026.100647_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105782","article-title":"Anti-diabetic drugs and weight loss in patients with type 2 diabetes","volume":"171","author":"Lazzaroni","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.advnut.2026.100647_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111617","article-title":"The effect of subcutaneous lixisenatide on weight loss in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomized controlled trials","volume":"210","author":"Sheng","year":"2024","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.advnut.2026.100647_bib97","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s13300-017-0241-z","article-title":"Effectiveness of liraglutide and lixisenatide in the treatment of type 2 diabetes: real-world evidence from The Health Improvement Network (THIN) database in the United Kingdom","volume":"8","author":"Feher","year":"2017","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.advnut.2026.100647_bib98","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076410","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.advnut.2026.100647_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.107040","article-title":"Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide","volume":"199","author":"Lunati","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.advnut.2026.100647_bib100","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.3390\/nu14132641","article-title":"Therapeutic benefits and dietary restrictions of fiber intake: a state of the art review","volume":"14","author":"Ioni\u021b\u0103-M\u00eendrican","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.advnut.2026.100647_bib101","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1039\/D2FO01096H","article-title":"Inulin: properties and health benefits","volume":"14","author":"Qin","year":"2023","journal-title":"Food Funct"},{"key":"10.1016\/j.advnut.2026.100647_bib102","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1111\/ijfs.16373","article-title":"Manipulating the kinetics and site of colonic fermentation with different fibre combinations \u2013 a review","volume":"58","author":"Ratanpaul","year":"2023","journal-title":"Int. J. Food Sci. Tech."},{"key":"10.1016\/j.advnut.2026.100647_bib103","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/gutjnl-2021-324784","article-title":"Psyllium reduces inulin-induced colonic gas production in IBS: MRI and in vitro fermentation studies","volume":"71","author":"Gunn","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.advnut.2026.100647_bib104","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41575-020-00375-4","article-title":"Dietary fibre in gastrointestinal health and disease","volume":"18","author":"Gill","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.advnut.2026.100647_bib105","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2197837","article-title":"Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial","volume":"15","author":"Lai","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.advnut.2026.100647_bib106","article-title":"Open label study of a novel fiber product for bloating, gas, and bowel regularity","volume":"12","author":"Ganz","year":"2025","journal-title":"Front. Med. (Lausanne)."},{"key":"10.1016\/j.advnut.2026.100647_bib107","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/00325481.2021.2002616","article-title":"Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice","volume":"134","author":"Wharton","year":"2022","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.advnut.2026.100647_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102661","article-title":"GLP-1 receptor agonists for weight reduction in people living with obesity but without diabetes: a living benefit\u2013harm modelling study","volume":"73","author":"Moll","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.advnut.2026.100647_bib109","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3390\/metabo15060381","article-title":"The effect of frailty on body composition and its impact on the use of SGLT-2 inhibitors and GLP-1RA in older persons with diabetes","volume":"15","author":"Sinclair","year":"2025","journal-title":"Metabolites"},{"key":"10.1016\/j.advnut.2026.100647_bib110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/jamainternmed.2024.3579","article-title":"GLP-1 receptor agonists and the path to sustainable obesity care","volume":"185","author":"Manne-Goehler","year":"2025","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.advnut.2026.100647_bib111","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.57349","article-title":"Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among US adults with overweight or obesity","volume":"8","author":"Rodriguez","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.advnut.2026.100647_bib112","first-page":"860","article-title":"Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes","volume":"30","author":"Gleason","year":"2024","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"10.1016\/j.advnut.2026.100647_bib113","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13668-025-00649-w","article-title":"Impact of GLP- 1 receptor agonist therapy in patients high risk for sarcopenia","volume":"14","author":"Memel","year":"2025","journal-title":"Curr. Nutr. Rep."},{"key":"10.1016\/j.advnut.2026.100647_bib114","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/JXX.0000000000000882","article-title":"Psyllium is a natural nonfermented gel-forming fiber that is effective for weight loss: a comprehensive review and meta-analysis","volume":"35","author":"Gibb","year":"2023","journal-title":"J. Am. Assoc. Nurse Pract."},{"key":"10.1016\/j.advnut.2026.100647_bib115","first-page":"S86","article-title":"Facilitating positive health behaviors and well-being to improve health outcomes: Standards of Care in Diabetes\u20142025","volume":"48","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.advnut.2026.100647_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1510564","article-title":"Dietary fiber influence on overall health, with an emphasis on CVD, diabetes, obesity, colon cancer, and inflammation","volume":"11","author":"Alahmari","year":"2024","journal-title":"Front. Nutr."},{"key":"10.1016\/j.advnut.2026.100647_bib117","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/jn\/nxz117","article-title":"Fiber intake predicts weight loss and dietary adherence in adults consuming calorie-restricted diets: the POUNDS Lost (Preventing Overweight Using Novel Dietary Strategies) study","volume":"149","author":"Miketinas","year":"2019","journal-title":"J. Nutr."},{"key":"10.1016\/j.advnut.2026.100647_bib118","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52103-x","article-title":"Metabolic and gut microbiome changes following GLP-1 or dual GLP-1\/GLP-2 receptor agonist treatment in diet-induced obese mice","volume":"9","author":"Madsen","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.advnut.2026.100647_bib119","article-title":"Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.advnut.2026.100647_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2021.101223","article-title":"Liraglutide and sitagliptin have no effect on intestinal microbiota composition: a 12-week randomized placebo-controlled trial in adults with type 2 diabetes","volume":"47","author":"Smits","year":"2021","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.advnut.2026.100647_bib121","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/phar.70007","article-title":"GLP-1RA-induced delays in gastrointestinal motility: predicted effects on coadministered drug absorption by PBPK analysis","volume":"45","author":"Hooper","year":"2025","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.advnut.2026.100647_bib122","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3390\/nu17081303","article-title":"Effects of GLP-1 analogues and agonists on the gut microbiota: a systematic review","volume":"17","author":"Gofron","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.advnut.2026.100647_bib123","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/gutjnl-2022-328166","article-title":"Advancing human gut microbiota research by considering gut transit time","volume":"72","author":"Proch\u00e1zkov\u00e1","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.advnut.2026.100647_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eujim.2017.12.011","volume":"18","author":"Roshanravan","year":"2018","journal-title":"Eur. J. Integr. Med."},{"key":"10.1016\/j.advnut.2026.100647_bib125","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000001789","article-title":"Impact of GLP-1 receptor agonists on whole-gut gastrointestinal motility using wireless motility capsule: a descriptive single-center case series","volume":"12","author":"Cymbal","year":"2025","journal-title":"ACG Case Rep. J."},{"key":"10.1016\/j.advnut.2026.100647_bib126","doi-asserted-by":"crossref","first-page":"8558","DOI":"10.1039\/D2FO01884E","article-title":"Dysregulation of intestinal flora: excess prepackaged soluble fibers damage the mucus layer and induce intestinal inflammation","volume":"13","author":"Chen","year":"2022","journal-title":"Food Funct"},{"key":"10.1016\/j.advnut.2026.100647_bib127","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.2147\/DMSO.S494919","article-title":"Dietary recommendations for the management of gastrointestinal symptoms in patients treated with GLP-1 receptor agonist","volume":"17","author":"Gentinetta","year":"2024","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.advnut.2026.100647_bib128","first-page":"843","article-title":"Bidirectional interactions between the gut microbiota and incretin-based therapies","volume":"15","author":"Trapanese","year":"2025","journal-title":"Life (Basel)"},{"key":"10.1016\/j.advnut.2026.100647_bib129","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s13300-021-01113-y","article-title":"Contemporary classification of glucagon-like peptide 1 receptor agonists (GLP1RAs)","volume":"12","author":"Kalra","year":"2021","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.advnut.2026.100647_bib130","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1073\/pnas.0710402105","article-title":"\u03b2-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic \u03b2 cells","volume":"105","author":"Sonoda","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.advnut.2026.100647_bib131","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqad028","article-title":"Enhanced endosomal signaling and desensitization of GLP-1R vs GIPR in pancreatic beta cells","volume":"164","author":"Manchanda","year":"2023","journal-title":"Endocrinology"},{"issue":"Suppl 3","key":"10.1016\/j.advnut.2026.100647_bib132","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.2337\/diabetes.53.suppl_3.S205","article-title":"Chronic exposure to GLP-1R agonists promotes homologous GLP-1 receptor desensitization in vitro but does not attenuate GLP-1R\u2013dependent glucose homeostasis in vivo","volume":"53","author":"Baggio","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.advnut.2026.100647_bib133","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/diacare.27.11.2628","article-title":"Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes","volume":"27","author":"Buse","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.advnut.2026.100647_bib134","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2337\/db10-0474","article-title":"Rapid tachyphylaxis of the glucagon-like peptide 1\u2013induced deceleration of gastric emptying in humans","volume":"60","author":"Nauck","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.advnut.2026.100647_bib135","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1080\/10408398.2022.2130160","article-title":"The role of dietary fibers in regulating appetite, an overview of mechanisms and weight consequences","volume":"64","author":"Akhlaghi","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.advnut.2026.100647_bib136","article-title":"Dietary intake by patients taking GLP-1 and dual GIP\/GLP-1 receptor agonists: a narrative review and discussion of research needs","volume":"11","author":"Christensen","year":"2024","journal-title":"Obes. Pillars."},{"key":"10.1016\/j.advnut.2026.100647_bib137","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1566498","article-title":"Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study","volume":"12","author":"Johnson","year":"2025","journal-title":"Front. Nutr."},{"issue":"9","key":"10.1016\/j.advnut.2026.100647_bib138","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jamainternmed.2025.1794","article-title":"Integrating diet and physical activity when prescribing GLP-1s\u2014lifestyle factors remain crucial","volume":"185","author":"Mehrtash","year":"2025","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.advnut.2026.100647_bib139","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/jcsm.12820","article-title":"Higher dietary fibre intake is associated with increased skeletal muscle mass and strength in adults aged 40 years and older","volume":"12","author":"Frampton","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.advnut.2026.100647_bib140","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.748477","article-title":"A combination of glucagon-like peptide-1 receptor agonist and dietary intervention could be a promising approach for obesity treatment","volume":"12","author":"Lee","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.advnut.2026.100647_bib141","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3892\/ijmm.2017.3072","article-title":"Dietary fiber in irritable bowel syndrome","volume":"40","author":"El-Salhy","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.advnut.2026.100647_bib142","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2337\/cd24-a008","article-title":"Section 8: obesity and weight management for the prevention and treatment of type 2 diabetes","volume":"42","year":"2024","journal-title":"Clin. Diabetes"},{"key":"10.1016\/j.advnut.2026.100647_bib143","unstructured":"National Health and Medical Research Council. Clinical practice guidelines for the management of overweight and obesity in adults, adolescents and children in Australia. Melbourne: National Health and Medical Research Council; 2013. NHMRC Reference code N57. https:\/\/extranet.who.int\/ncdccs\/Data\/AUS_D1bic_n57-obesity-guidelines-.pdf"},{"key":"10.1016\/j.advnut.2026.100647_bib144","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/MCG.0b013e318259bd04","article-title":"World Gastroenterology Organisation global guidelines on obesity","volume":"46","author":"Mathus-Vliegen","year":"2012","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.advnut.2026.100647_bib145","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.3390\/nu14132627","article-title":"Prolonged isolated soluble dietary fibre supplementation in overweight and obese patients: a systematic review with meta-analysis of randomised controlled trials","volume":"14","author":"Huwiler","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.advnut.2026.100647_bib146","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3945\/ajcn.117.163246","article-title":"Effects of isolated soluble fiber supplementation on body weight, glycemia, and insulinemia in adults with overweight and obesity: a systematic review and meta-analysis of randomized controlled trials","volume":"106","author":"Thompson","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.advnut.2026.100647_bib147","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.927859","article-title":"Use of GLP-1 receptor agonists and occurrence of thyroid disorders: a meta-analysis of randomized controlled trials","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.advnut.2026.100647_bib148","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mcna.2017.08.012","article-title":"Maintenance of lost weight and long-term management of obesity","volume":"102","author":"Hall","year":"2018","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.advnut.2026.100647_bib149","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1161\/01.cir.0000437739.71477.ee","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.advnut.2026.100647_bib150","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an endocrine Society clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.advnut.2026.100647_bib151","first-page":"434","article-title":"World Health Organization guideline on the use and indications of glucagon-like peptide-1 therapies for the treatment of obesity in adults","volume":"335","author":"Celletti","year":"2026","journal-title":"JAMA. 2025"},{"key":"10.1016\/j.advnut.2026.100647_bib152","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1037\/amp0000517","article-title":"Lifestyle modification approaches for the treatment of obesity in adults","volume":"75","author":"Wadden","year":"2020","journal-title":"Am. Psychol."},{"key":"10.1016\/j.advnut.2026.100647_bib153","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2337\/dsi24-0001","article-title":"A guideline-directed approach to obesity treatment","volume":"37","author":"Chao","year":"2024","journal-title":"Diabetes Spectr"},{"key":"10.1016\/j.advnut.2026.100647_bib154","series-title":"WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults","year":"2025"},{"key":"10.1016\/j.advnut.2026.100647_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103363","article-title":"The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions","volume":"86","author":"Moiz","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.advnut.2026.100647_bib156","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/sms.14269","article-title":"Long-term effects on weight loss and maintenance by intensive start with diet and exercise","volume":"33","author":"Kaikkonen","year":"2023","journal-title":"Scand. J. Med. Sci. Sports."},{"key":"10.1016\/j.advnut.2026.100647_bib157","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1110748","article-title":"Increased dietary fiber is associated with weight loss among Full Plate Living program participants","volume":"10","author":"Kelly","year":"2023","journal-title":"Front. Nutr."}],"container-title":["Advances in Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216183132600061X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216183132600061X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:45:40Z","timestamp":1783122340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216183132600061X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":157,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S216183132600061X"],"URL":"https:\/\/doi.org\/10.1016\/j.advnut.2026.100647","relation":{},"ISSN":["2161-8313"],"issn-type":[{"value":"2161-8313","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dietary Fiber and Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Converging Mechanisms, Interactions, and Strategies for Durable Weight Control","name":"articletitle","label":"Article Title"},{"value":"Advances in Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advnut.2026.100647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Nutrition.","name":"copyright","label":"Copyright"}],"article-number":"100647"}}